Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorThe ESHRE COVID-19 Working Group-
dc.contributor.authorVermeulen, Nathalie-
dc.contributor.authorAta, Baris-
dc.contributor.authorGianaroli, Luca-
dc.contributor.authorLundin, Kersti-
dc.contributor.authorMocanu, Edgar-
dc.contributor.authorRautakallio Hokkanen, Satu-
dc.contributor.authorTapanainen, Juha S.-
dc.contributor.authorVeiga, Anna-
dc.description.abstractStudy question: How did coronavirus disease 2019 (COVID-19) impact on medically assisted reproduction (MAR) services in Europe during the COVID-19 pandemic (March to May 2020)? Summary answer: MAR services, and hence treatments for infertile couples, were stopped in most European countries for a mean of 7 weeks. Main results and the role of chance: By aligning the data for each country with respective epidemiological data, we show a large variation in the time and the phase in the epidemic in the curve when MAR/ART treatments were suspended and restarted. Similarly, the duration of interruption varied. Fertility preservation treatments and patient supportive care for patients remained available during the pandemic.-
dc.format.extent8 p.-
dc.publisherOxford University Press (OUP)-
dc.relation.isformatofReproducció del document publicat a:
dc.relation.ispartofHuman Reproduction Open, 2020, vol. 2020, issue. 3-
dc.rightscc by-nc (c) The ESHRE COVID-19 Working Group, 2020-
dc.subject.classificationReproducció humana assistida-
dc.subject.otherHuman reproductive technology-
dc.titleA picture of medically assisted reproduction activities during the COVID-19 pandemic in Europe-
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
hoaa035.pdf933.75 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons